These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29549533)

  • 1. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
    Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
    Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment.
    Iravani A; Turgeon GA; Akhurst T; Callahan JW; Bressel M; Everitt SJ; Siva S; Hofman MS; Hicks RJ; Ball DL; Mac Manus MP
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1869-1877. PubMed ID: 31190177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.
    Castillo R; Pham N; Ansari S; Meshkov D; Castillo S; Li M; Olanrewaju A; Hobbs B; Castillo E; Guerrero T
    Radiat Oncol; 2014 Mar; 9():74. PubMed ID: 24625207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in lung injury after IMRT or proton therapy assessed by
    Shusharina N; Liao Z; Mohan R; Liu A; Niemierko A; Choi N; Bortfeld T
    Radiother Oncol; 2018 Jul; 128(1):147-153. PubMed ID: 29352608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
    Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
    Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
    J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial.
    Wang XS; Shi Q; Mendoza T; Lin S; Chang JY; Bokhari RH; Lin HK; Garcia-Gonzalez A; Kamal M; Cleeland CS; Liao Z
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):100-107. PubMed ID: 31627177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer.
    Yue J; McKeever M; Sio TT; Xu T; Huo J; Shi Q; Nguyen QN; Komaki R; Gomez DR; Pan T; Wang XS; Liao Z
    Clin Transl Radiat Oncol; 2017 Jun; 4():1-7. PubMed ID: 29594201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer.
    Moreno M; Aristu J; Ramos LI; Arbea L; López-Picazo JM; Cambeiro M; Martínez-Monge R
    Clin Transl Oncol; 2007 Sep; 9(9):596-602. PubMed ID: 17921108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.
    Petit SF; van Elmpt WJ; Oberije CJ; Vegt E; Dingemans AM; Lambin P; Dekker AL; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):698-705. PubMed ID: 20884128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].
    Zhang Y; Yu YH; Yu JM; He W; Fu Z; Guo SF; Liu XJ; Cong CS
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):622-5. PubMed ID: 20021952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
    Szejniuk WM; Nielsen MS; Takács-Szabó Z; Pawlowski J; Al-Saadi SS; Maidas P; Bøgsted M; McCulloch T; Frøkjær JB; Falkmer UG; Røe OD
    Radiat Oncol; 2021 Jul; 16(1):131. PubMed ID: 34266462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute radiation oesophagitis associated with 2-deoxy-2-[18F]fluoro-d-glucose uptake on positron emission tomography/CT during chemo-radiation therapy in patients with non-small-cell lung cancer.
    Everitt S; Callahan J; Obeid E; Hicks RJ; Mac Manus M; Ball D
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):682-688. PubMed ID: 28608503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy.
    Koto M; Tsujii H; Yamamoto N; Nishimura H; Yamada S; Miyamoto T
    Tohoku J Exp Med; 2007 Oct; 213(2):149-56. PubMed ID: 17917408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.
    Jahangiri P; Pournazari K; Torigian DA; Werner TJ; Swisher-McClure S; Simone CB; Alavi A
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):206-216. PubMed ID: 30229527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.